A study by Daud et al. [22] revealed that an increase in the fraction of a certain type of CD8+ T cells with high expression of PD-1 and CTLA-4 (PD-1high/CTLA-4high) in metastatic melanoma correlates with response to anti-PD-1 treatment. This evidence concerns the gene CTLA4 and metastatic melanoma.